These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 31153385)

  • 21. Dermatomyositis Identified During Palliative Care Management for Chemotherapy-Associated Pain: A Case Report.
    Hamada H; Tanoue T; Saito O; Endo M; Miyazaki K; Miyasato A; Iketani S; Sugimori A; Watanabe C; Uchino H
    J Palliat Care; 2022 Apr; 37(2):83-86. PubMed ID: 34823395
    [No Abstract]   [Full Text] [Related]  

  • 22. Asymptomatic Myocarditis with Mild Cardiac Marker Elevation Following Nivolumab-Induced Myositis.
    Shindo A; Yamasaki M; Uchino K; Yamasaki M
    Int Heart J; 2022; 63(1):180-183. PubMed ID: 35095069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
    Aslanidis S; Pyrpasopoulou A; Kartali N; Zamboulis C
    Clin Rheumatol; 2007 Jul; 26(7):1198-200. PubMed ID: 16779504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune checkpoint-mediated myositis and myasthenia gravis: A case report and review of evaluation and management.
    Kang KH; Grubb W; Sawlani K; Gibson MK; Hoimes CJ; Rogers LR; Lavertu P; Yao M
    Am J Otolaryngol; 2018; 39(5):642-645. PubMed ID: 29903623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An autopsy case of nivolumab-induced myasthenia gravis and myositis].
    Sawai T; Hosokawa T; Shigekiyo T; Ogawa S; Sano E; Arawaka S
    Rinsho Shinkeigaku; 2019 Jun; 59(6):360-364. PubMed ID: 31142711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of IVIG in the Treatment of Autoimmune Conditions With Concurrent Immune Checkpoint Inhibitors for Metastatic Cancer.
    Punekar SR; Castillo R; Sandigursky S; Cho DC
    J Immunother; 2021 Oct; 44(8):335-337. PubMed ID: 34166301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune Checkpoint Inhibitor-Induced Myositis: a Case Report and Literature Review.
    Kadota H; Gono T; Shirai Y; Okazaki Y; Takeno M; Kuwana M
    Curr Rheumatol Rep; 2019 Feb; 21(4):10. PubMed ID: 30790071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapidly progressive myositis as the sole manifestation of a concurrent gastric carcinoma.
    Asadi M; Javanbakht M; Khajavian S; Zand S
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22791857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation.
    Valenti-Azcarate R; Esparragosa Vazquez I; Toledano Illan C; Idoate Gastearena MA; Gállego Pérez-Larraya J
    Neuromuscul Disord; 2020 Jan; 30(1):67-69. PubMed ID: 31839404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potential mechanism of the onset of acute eosinophilic pneumonia triggered by an anti-PD-1 immune checkpoint antibody in a lung cancer patient.
    Jodai T; Yoshida C; Sato R; Kakiuchi Y; Sato N; Iyama S; Kimura T; Saruwatari K; Saeki S; Ichiyasu H; Fujii K; Tomita Y
    Immun Inflamm Dis; 2019 Mar; 7(1):3-6. PubMed ID: 30461210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nivolumab-induced synchronous occurrence of myositis and hypothyroidism in a patient with squamous cell lung cancer.
    Badovinac S; Korsic M; Zarkovic K; Mursic D; Roglic M; Jakopovic M; Samarzija M
    Immunotherapy; 2018 Mar; 10(6):427-431. PubMed ID: 29562858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dermatomyositis associated with metastatic rectal adenocarcinoma: case report].
    Vesić S; Daković Z; Vukićević J; Vuković J; Stojković J; Medenica L
    Med Pregl; 2009; 62(9-10):473-5. PubMed ID: 20391745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bicytopenia in Primary Lung Melanoma Treated with Nivolumab.
    Takahashi A; Kubo A; Mizuno S; Kasai K; Asai N; Yonezawa T; Kosaka K; Nishimura M; Tanaka H; Yokoe N; Tsuzuki T; Takami A; Yamaguchi E
    Intern Med; 2019 Mar; 58(6):827-831. PubMed ID: 30449777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature.
    Chou JW; Lin YL; Cheng KS; Wu PY; Reanne Ju T
    Intern Med; 2017; 56(14):1831-1837. PubMed ID: 28717078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nivolumab-related myasthenia gravis with myositis requiring prolonged mechanical ventilation: a case report.
    Saishu Y; Yoshida T; Seino Y; Nomura T
    J Med Case Rep; 2022 Feb; 16(1):61. PubMed ID: 35152911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
    Kamo H; Hatano T; Kanai K; Aoki N; Kamiyama D; Yokoyama K; Takanashi M; Yamashita Y; Shimo Y; Hattori N
    BMC Neurol; 2019 Aug; 19(1):184. PubMed ID: 31382909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer: A case report.
    Tanabe K; Kanzaki H; Wada T; Nakashima Y; Sugiyama H; Okada H; Wada J
    Medicine (Baltimore); 2020 May; 99(21):e20464. PubMed ID: 32481351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report.
    Yonezaki K; Kobayashi T; Imachi H; Yoshimoto T; Kikuchi F; Fukunaga K; Sato S; Ibata T; Yamaji N; Lyu J; Dong T; Murao K
    J Med Case Rep; 2018 Jun; 12(1):171. PubMed ID: 29914537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myositis and myasthenia during nivolumab administration for advanced lung cancer: a case report and review of the literature.
    Veccia A; Kinspergher S; Grego E; Peterlana D; Berti A; Tranquillini E; Caffo O
    Anticancer Drugs; 2020 Jun; 31(5):540-544. PubMed ID: 32011360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.